Source: Journal of Pharmacology and Experimental Therapeutics. Unidade: ICB
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WALLACE, John L. et al. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics, v. 309, p. 626-633, 2004Tradução . . Acesso em: 01 jun. 2024.APA
Wallace, J. L., Muscará, M. N., De Nucci, G., Zamuner, S. R., Cirino, G., Soldato, P. del, & Ongini, E. (2004). Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics, 309, 626-633.NLM
Wallace JL, Muscará MN, De Nucci G, Zamuner SR, Cirino G, Soldato P del, Ongini E. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics. 2004 ; 309 626-633.[citado 2024 jun. 01 ]Vancouver
Wallace JL, Muscará MN, De Nucci G, Zamuner SR, Cirino G, Soldato P del, Ongini E. Gastric tolerability and prolonged prostaglandin inhibition in the brain with a nitric oxide-releasing flurbiprofen derivative, NCX-2216[3-[4-(2-fluoro-alpha-methyl-[1,1'-biphenyl]-4-acetyloxy)-3-methoxyphenyl]-2-propenoicacid-4-nitrooxybutyl ester]. Journal of Pharmacology and Experimental Therapeutics. 2004 ; 309 626-633.[citado 2024 jun. 01 ]